Diabetic retinopathy involves anatomic changes in retinal vessels and neuroglia. The pathogenetic mechanism responsible for retinopathy is imperfectly understood, but much of the mechanism is apparently reproduced by experimental diabetes in animals and by chronic elevation of blood galactose in nondiabetic animals. The evidence that retinopathy is a consequence of excessive blood sugars and their sequelae is consistent with a demonstrated inhibition of retinopathy by strict glycemic control in diabetic dogs. However, retinopathy in the dog model has shown a tendency to resist intervention by strict control. Biochemical and pathophysiological sequelae of hyperglycemia possibly critical to the development of retinopathy in humans and animal models are being studied in many laboratories. Retinopathy occurs in experimental galactosemia in the absence of the renal hypertrophy, mesangial expansion, and glomerular obliteration typical of diabetes in humans and dogs, implying that retinopathy and nephropathydiffer appreciably in pathogenesis.
Skip Nav Destination
Article navigation
Perspectives in Diabetes|
October 01 1989
Pathogenesis of Diabetic Retinopathy
Ronald L Engerman
Ronald L Engerman
Department of Ophthalmology, University of Wisconsin
Madison, Wisconsin
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Ronald L. Engerman, Department of Ophthalmology, University of Wisconsin, 1300 University Avenue, Madison, Wl 53706.
Diabetes 1989;38(10):1203–1206
Article history
Received:
May 24 1989
Accepted:
June 06 1989
PubMed:
2676655
Citation
Ronald L Engerman; Pathogenesis of Diabetic Retinopathy. Diabetes 1 October 1989; 38 (10): 1203–1206. https://doi.org/10.2337/diab.38.10.1203
Download citation file:
3,015
Views